Sections

Dermatology Section

 Board 2019 - 2021

Chairperson

Charlotte Mortz

Secretary
Barbara Ballmer-Weber

Past Chair 2017-2019
Knut Brockow

Board Members
Maria Bova
Jose Luis Garcia-Abujeta
Margarida Goncalo
Elena Petkova

JM Representative   
Daniela Carvalho





Interview with Charlotte Mortz, Odense Hospital University, 

and Knut Brockow, Munich Technical University
June 2019

Charlotte Mortz and Knut Brockow discuss the importance and prevalence of skin allergy.

“Between 20-30% of the population has had skin allergy at some point in their lives (…)
A disease like atopic dermatitis affects 20% of all children at some point in their childhood”






  Interview with Peter Schmid-Grendelmeier, University of Zürich
June 2019

Peter Schmid-Grendelmeier discusses the biggest challenges in allergic
skin diseases and highlights European priorities in the field.

““In the field of allergic skin diseases (there is) an increase of atopic dermatitis,
which is a global problem, (…) an a rapid increase in some contact allergens that cause contact dermatitis”



 

Last updated 26 June 2019
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel